Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Negusse Habtemichael

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gene|February 28, 2002
Cloning the AFURS1 gene which is up-regulated in senescent human parenchymal kidney cellsNegusse Habtemichael, Gyula Kovacs
EMBO Reports|November 14, 2006
The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and functionShirley K Knauer, Carolin Bier, Negusse Habtemichael, et al.
Scientific Reports|November 4, 2017
Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA functionAlena Gribko, Angelina Hahlbrock, Sebastian Strieth, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2005
Patient-based cross-platform comparison of oligonucleotide microarray expression profilesJoerg Schlingemann, Negusse Habtemichael, Carina Ittrich, et al.
Biological Chemistry|August 27, 2021
Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancerDésirée Gül, Negusse Habtemichael, Dimo Dietrich, et al.
Scientific Reports|May 11, 2018
Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancersDorothee Goesswein, Negusse Habtemichael, Aslihan Gerhold-Ay, et al.
Gene|August 24, 2010
Cloning and functional characterization of the guinea pig apoptosis inhibitor protein SurvivinNegusse Habtemichael, Desiree Wünsch, Carolin Bier, et al.
Human Mutation|November 20, 2012
Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patientsShirley K Knauer, Britta Unruhe, Sarah Karczewski, et al.
Molecular and Cellular Neurosciences|July 15, 2010
Expression analysis suggests a potential cytoprotective role of Birc5 in the inner earNegusse Habtemichael, Ulf-Rüdiger Heinrich, Shirley K Knauer, et al.
International Journal of Cancer|January 9, 2009
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivinVerena Fetz, Carolin Bier, Negusse Habtemichael, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gene|February 28, 2002
Cloning the AFURS1 gene which is up-regulated in senescent human parenchymal kidney cellsNegusse Habtemichael, Gyula Kovacs
EMBO Reports|November 14, 2006
The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and functionShirley K Knauer, Carolin Bier, Negusse Habtemichael, et al.
Scientific Reports|November 4, 2017
Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA functionAlena Gribko, Angelina Hahlbrock, Sebastian Strieth, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2005
Patient-based cross-platform comparison of oligonucleotide microarray expression profilesJoerg Schlingemann, Negusse Habtemichael, Carina Ittrich, et al.
Biological Chemistry|August 27, 2021
Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancerDésirée Gül, Negusse Habtemichael, Dimo Dietrich, et al.
Scientific Reports|May 11, 2018
Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancersDorothee Goesswein, Negusse Habtemichael, Aslihan Gerhold-Ay, et al.
Gene|August 24, 2010
Cloning and functional characterization of the guinea pig apoptosis inhibitor protein SurvivinNegusse Habtemichael, Desiree Wünsch, Carolin Bier, et al.
Human Mutation|November 20, 2012
Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patientsShirley K Knauer, Britta Unruhe, Sarah Karczewski, et al.
Molecular and Cellular Neurosciences|July 15, 2010
Expression analysis suggests a potential cytoprotective role of Birc5 in the inner earNegusse Habtemichael, Ulf-Rüdiger Heinrich, Shirley K Knauer, et al.
International Journal of Cancer|January 9, 2009
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivinVerena Fetz, Carolin Bier, Negusse Habtemichael, et al.
Pageof 2